Trial intelligence / Profile preview

3D-TEBE for Traumatic Bone Defects

NCT03103295Phase 2Unknown

Sponsor
AA-Partners
Start
Nov 2015
Primary completion
Dec 2018
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of 3D-Tissue Engineered Bone Equivalent in Bone defect, sponsored by AA-Partners. Status: unknown.

02

Drugs

3D-Tissue Engineered Bone Equivalent
03

Conditions

Bone defect

Beyond the preview

Go deeper on NCT03103295.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03103295.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call